Literature DB >> 9089435

Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design.

N P Todorov1, P M Dean.   

Abstract

We describe an algorithm for the automated generation of molecular structures subject to geometric and connectivity constraints. The method relies on simulated annealing and simplex optimization of a penalty function that contains a variety of conditions and can be useful in structure-based drug design projects. The procedure controls the diversity and complexity of the generated molecules. Structure selection filters are an integral part and drive the algorithm. Several procedures have been developed to achieve reliable control. A number of template sets can be defined and combined to control the range of molecules which are searched. Ring systems are predefined. Normally, the ring-system complexity is on of the most elusive and difficult factors to control when fusion-, bridge- and spiro-structures are built by joining templates. Here this is not an issue; the decision about which systems are acceptable, and which are not, is made before the run is initiated. Queries for inclusion and exclusion spheres are incorporated into the objective function, and, by using a flexible notation, the structure generation can be directed and more focused. Simulated annealing is a reliable optimizer and converges asymptotically to the global minimum. The objective functions used here are degenerate, so it is likely that each run will produce a different set of good solutions.

Mesh:

Substances:

Year:  1997        PMID: 9089435     DOI: 10.1023/a:1008042711516

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  28 in total

1.  Automated site-directed drug design using molecular lattices.

Authors:  R A Lewis; D C Roe; C Huang; T E Ferrin; R Langridge; I D Kuntz
Journal:  J Mol Graph       Date:  1992-06

Review 2.  3D database searching in drug design.

Authors:  Y C Martin
Journal:  J Med Chem       Date:  1992-06-12       Impact factor: 7.446

3.  Functionality maps of binding sites: a multiple copy simultaneous search method.

Authors:  A Miranker; M Karplus
Journal:  Proteins       Date:  1991

4.  Flexible ligand docking using a genetic algorithm.

Authors:  C M Oshiro; I D Kuntz; J S Dixon
Journal:  J Comput Aided Mol Des       Date:  1995-04       Impact factor: 3.686

5.  The atom assignment problem in automated de novo drug design. 1. Transferability of molecular fragment properties.

Authors:  M T Barakat; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1995-08       Impact factor: 3.686

6.  An exploration of a novel strategy for superposing several flexible molecules.

Authors:  T D Perkins; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1993-04       Impact factor: 3.686

7.  SPROUT: recent developments in the de novo design of molecules.

Authors:  V J Gillet; W Newell; P Mata; G Myatt; S Sike; Z Zsoldos; A P Johnson
Journal:  J Chem Inf Comput Sci       Date:  1994 Jan-Feb

8.  Meeting on binding sites: characterizing and satisfying steric and chemical restraints. University of York, 28-30 March 1993.

Authors:  T Slater; D Timms
Journal:  J Mol Graph       Date:  1993-12

9.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

10.  Automated molecular design: a new fragment-joining algorithm.

Authors:  A R Leach; S R Kilvington
Journal:  J Comput Aided Mol Des       Date:  1994-06       Impact factor: 3.686

View more
  11 in total

1.  A new method for estimating the importance of hydrogen-bonding groups in the binding site of a protein.

Authors:  Matthew D Kelly; Ricardo L Mancera
Journal:  J Comput Aided Mol Des       Date:  2003-07       Impact factor: 3.686

2.  A validation study on the practical use of automated de novo design.

Authors:  Martin Stahl; Nikolay P Todorov; Tim James; Harald Mauser; Hans-Joachim Boehm; Philip M Dean
Journal:  J Comput Aided Mol Des       Date:  2002-07       Impact factor: 3.686

3.  The effect of a tightly bound water molecule on scaffold diversity in the computer-aided de novo ligand design of CDK2 inhibitors.

Authors:  Alfonso T García-Sosa; Ricardo L Mancera
Journal:  J Mol Model       Date:  2005-12-23       Impact factor: 1.810

4.  The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA.

Authors:  Andreas Schüller; Marcel Suhartono; Uli Fechner; Yusuf Tanrikulu; Sven Breitung; Ute Scheffer; Michael W Göbel; Gisbert Schneider
Journal:  J Comput Aided Mol Des       Date:  2007-12-07       Impact factor: 3.686

Review 5.  Chemical genomics: a challenge for de novo drug design.

Authors:  P M Dean
Journal:  Mol Biotechnol       Date:  2007-06-30       Impact factor: 2.695

6.  CONFIRM: connecting fragments found in receptor molecules.

Authors:  David C Thompson; R Aldrin Denny; Ramaswamy Nilakantan; Christine Humblet; Diane Joseph-McCarthy; Eric Feyfant
Journal:  J Comput Aided Mol Des       Date:  2008-07-09       Impact factor: 3.686

7.  A branch-and-bound method for optimal atom-type assignment in de novo ligand design.

Authors:  N P Todorov; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

8.  De novo design by pharmacophore-based searches in fragment spaces.

Authors:  Tobias Lippert; Tanja Schulz-Gasch; Olivier Roche; Wolfgang Guba; Matthias Rarey
Journal:  J Comput Aided Mol Des       Date:  2011-09-16       Impact factor: 3.686

9.  Drug design for ever, from hype to hope.

Authors:  G Seddon; V Lounnas; R McGuire; T van den Bergh; R P Bywater; L Oliveira; G Vriend
Journal:  J Comput Aided Mol Des       Date:  2012-01-18       Impact factor: 3.686

Review 10.  Docking, virtual high throughput screening and in silico fragment-based drug design.

Authors:  Vincent Zoete; Aurélien Grosdidier; Olivier Michielin
Journal:  J Cell Mol Med       Date:  2009-01-21       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.